ライフサイエンスコーパス: RRT

1 RRT estimated that 10.4% of farmers killed badgers in th

2 RRT predictors (all shown as OR [95% CI]) included femal

3 There were 344 RRT calls during the study period.

4 rts from 584 inpatients involved in over 600 RRT events recorded in 2015.

5 r Mexican families when attempting to access RRT.

6 estimated the gap between needed and actual RRT, and projected needs to 2030.

7 poses clinical practice guidelines for acute RRT in Ebola virus disease.

8 Patients who require acute RRT have a significant risk of mortality and long-term d

9 Through technological advances, RRT can be offered to patients who are older and more fr

10 After RRT implementation, the mean monthly mortality rate decr

11 code rates outside of the ICU setting after RRT implementation at an academic children's hospital.

12 AKI-RRT is common among critically ill patients with COVID-1

13 creatinine level or AKI-RRT, as well as AKI-RRT or in-hospital mortality (RRT/death).

14 f 637 of 3099 patients (20.6%) developed AKI-RRT within 14 days of ICU admission, 350 of whom (54.9%)

15 ffered from vehicle accidents developing AKI-RRT during hospitalization were identified, and matching

16 ient-and hospital-level risk factors for AKI-RRT and to examine risk factors for 28-day mortality amo

17 Patient-level risk factors for AKI-RRT included CKD, men, non-White race, hypertension, dia

18 re doubling of serum creatinine level or AKI-RRT, as well as AKI-RRT or in-hospital mortality (RRT/de

19 es have focused on AKI treated with RRT (AKI-RRT).

20 AKI requiring renal replacement therapy (AKI-RRT).

21 r propensity matching with non-traumatic AKI-RRT cases with similar demographic and clinical characte

22 spite severe injuries, vehicle-traumatic AKI-RRT patients had better long-term survival than non-trau

23 non-traumatic AKI-RRT, vehicle-traumatic AKI-RRT patients had longer length of stay in hospital [medi

24 Vehicle-traumatic AKI-RRT patients had lower rates of long-term mortality (adj

25 that focused on ESKD, vehicle-traumatic AKI-RRT patients were associated with lower ESKD rates (HR,

26 e identified, and matching non-traumatic AKI-RRT patients were identified between 2000 and 2010.

27 er long-term survival than non-traumatic AKI-RRT patients, but a similar risk of ESKD.

28 546 vehicle-traumatic AKI-RRT patients, median age 47.6 years (interquartile range

29 0.894-1.438; p = 0.301) as non-traumatic AKI-RRT patients.

30 325-0.937; p = 0.028) than non-traumatic AKI-RRT patients.

31 Compared to non-traumatic AKI-RRT, vehicle-traumatic AKI-RRT patients had longer lengt

32 ng-term outcomes after vehicle-traumatic AKI-RRT.

33 s), 403 of the 637 patients (63.3%) with AKI-RRT had died, 216 (33.9%) were discharged, and 18 (2.8%)

34 ors of 28-day mortality in patients with AKI-RRT were older age, severe oliguria, and admission to a

35 The deployment of an RRT led by physician assistants with specialized skills

36 Implementation of an RRT was associated with a statistically significant redu

37 Therapeutic interventions and RRT have limited influence on the outcome of AKI, and a

38 dex, diabetes, hypertension, intubation, and RRT.

39 d not recover kidney function at 1 month and RRT at time of LT was the only factor associated with th

40 In-hospital mortality and RRT rates increased from 4.3% and 0%, respectively, for

41 ; combined mortality, stroke, paraplegia and RRT outcome was 12.8%.

42 A simulation-based estimate of age at RRT for 99% of the glomerular population was 37.9 years

43 The IPC-based RRT-PCR detected inhibitors in blood, kidney, lungs, spl

44 n people might have died prematurely because RRT could not be accessed.

45 From study entry to 18 months before RRT, GFR declined 7% faster among cases compared with co

46 ntrols (P<0.001) during the 18 months before RRT.

47 l of renal patients to a nephrologist before RRT is significantly associated with reduced access to r

48 or Medicaid beneficiaries in the year before RRT and who had been diagnosed with renal disease more t

49 or Medicaid beneficiaries in the year before RRT and who had been diagnosed with renal disease more t

50 d with renal disease more than 1 year before RRT.

51 sed with renal disease more than 1 yr before RRT.

52 is of children ages 2-19 years old beginning RRT from 1995 to 2011 using the US Renal Data System.

53 lly sound criteria for the agreement between RRT and AR that allow keeping the FN under control.

54 ion of viral RNA and subsequent detection by RRT-PCR.

55 mplification of the viral RNA and the IPC by RRT-PCR were monitored with two different fluorescent pr

56 stent with heart failure if fluid removal by RRT is delayed.

57 tion occurs before or after fluid removal by RRT.

58 patients aged >65 yr with new-onset chronic RRT who were New Jersey Medicare and/or Medicaid benefic

59 ohort of all patients with new-onset chronic RRT who were New Jersey Medicare and/or Medicaid benefic

60 n, intermittent hemodialysis, and continuous RRT are used to manage complications of medically refrac

61 y post-OLTx, n=17; and group III: continuous RRT post-OLTx, n=70.

62 ammonia levels, 61 (18%) were on continuous RRT (CRRT), 59 (17%) were on intermittent RRT (IRRT), an

63 ential severe complications of AKI, delaying RRT is a valid and safe strategy that may also allow for

64 mong critically ill patients with AKI, early RRT compared with delayed initiation of RRT reduced mort

65 dependently predictive of the need for early RRT and in combination formed a parsimonious model that

66 The need for early RRT was strongly associated with death before hospital d

67 rces than patients who did not require early RRT, spending more time in intensive care (15 +/- 13 d v

68 ctions of which patients would require early RRT.

69 Twenty-eight patients required early RRT (RRT initiated within 1 wk of transplant); 23 for co

70 Patients requiring early RRT consumed more healthcare resources than patients who

71 g severe AKI allowed many patients to escape RRT and did not seem to adversely affect survival compar

72 llow-up of 4.9 years, chronic renal failure, RRT, all fractures, hip fractures, and vertebral fractur

73 al (< or = 90 days vs. >90 days before first RRT) and socioeconomic status (lower socioeconomic statu

74 tinuous veno-venous hemodialysis (CVVHD) for RRT has been reported in three series of OLTX patients w

75 amma models were fitted and extrapolated for RRT overall and by specific treatment modality (dialysis

76 hospital or ICU length of stay, or need for RRT after hospital discharge.

77 The need for RRT has increased along with waiting time in OLTX patien

78 point of all-cause mortality or the need for RRT in a secondary analysis of a prospective observation

79 e independently associated with the need for RRT in the early posttransplant period.

80 acute renal failure and reduce the need for RRT postoperatively are needed.

81 Patients developing the need for RRT postoperatively have an increased 90-day mortality a

82 nts at high risk for developing the need for RRT postoperatively.

83 for prediction of progressive AKI, need for RRT, and inpatient mortality.

84 outcomes included lengths of stay, need for RRT, and mortality.

85 urs or >/=50% within 5 days, or the need for RRT.

86 e and urine output domains with the risk for RRT and likelihood of renal recovery and survival using

87 tes in 2001-2002, and mortality hazards from RRT initiation, relative to hazards in 2001-2002.

88 The matrix gene RRT-PCR assay has a detection limit of 10 fg or approxim

89 susceptible to TCV because of a second gene, RRT, that regulates resistance to TCV.

90 n the early group than in the delayed group (RRT: 9 days [Q1, Q3: 4, 44] in the early group vs 25 day

91 In the buffered crystalloid group, RRT was used in 38 of 1152 patients (3.3%) compared with

92 In all CHA(2)DS(2)-VASc risk groups, RRT was independently associated with a higher risk of s

93 rvival compared with a strategy of immediate RRT.

94 red prognostic information and can assist in RRT planning efforts for children with moderate-to-sever

95 shifts in the population and improvements in RRT.

96 nous application of SA confers resistance in RRT-containing plants by increasing HRT transcript level

97 Although the future incident RRT population will be determined in part by population

98 The reduction in incident RRT, not death, drove this effect on the composite among

99 s with CKD experience less death or incident RRT when treated with off-pump compared with on-pump CAB

100 ted for most of the increase in the incident RRT population in all age groups during this time period

101 Similarly, the incident RRT population increased substantially in all age groups

102 T-free when the corresponding case initiated RRT (controls).

103 Children (n=125) who initiated RRT (cases) during follow-up were individually matched b

104 arify to what extent the delay in initiating RRT can be prolonged.

105 us RRT (CRRT), 59 (17%) were on intermittent RRT (IRRT), and 220 (65%) received no RRT for the first

106 is, the strongest factor predicting lessened RRT and NRM was nonmyeloablative conditioning, whereas h

107 clusion, nonmyeloablative regimens had lower RRT and NRM and could be considered for comparative stud

108 as well as AKI-RRT or in-hospital mortality (RRT/death).

109 rted all-cause and cardiovascular mortality, RRT, kidney function, BP, and adverse events.

110 t differences in kidney function, mortality, RRT, cardiovascular events, or pulmonary edema.

111 tly no significant differences in mortality, RRT, or cardiovascular events but heterogeneous effects

112 Eight patients had severe AKI, necessitating RRT.

113 g ESRD due to multiple myeloma necessitating RRT in the United States, we evaluated temporal trends b

114 We estimated the number of patients needing RRT to be between 4.902 million (95% CI 4.438-5.431 mill

115 eligible patients, 22 patients (13 SRT, nine RRT) participated in a battery of tests that included in

116 by 38%, 23%, and 19% with CRRT, IRRT, and no RRT, respectively.

117 studied, which were divided into group I: no RRT, n=637; group II: hemodialysis only post-OLTx, n=17;

118 ittent RRT (IRRT), and 220 (65%) received no RRT for the first 2 days.

119 Comparing to no RRT use, whereas ammonia reduction with CRRT was signifi

120 es, and contacted national experts to obtain RRT prevalence data.

121 id, serum, or tracheal swabs The accuracy of RRT-PCR test results with the lyophilized beads was test

122 of AKI and prompt, judicious application of RRT may also improve outcomes.

123 igher rate of death during the first 90 d of RRT compared with HD patients (hazard ratio [HR], 1.16;

124 l for the first known successful delivery of RRT with subsequent renal recovery in a patient with Ebo

125 Duration of RRT and length of hospital stay were significantly short

126 Second, we studied the effect of RRT on ammonia for the first 3 days post study admission

127 utation, overcame the suppressive effects of RRT and enhanced resistance to TCV, provided the HRT all

128 This study provides the first estimate of RRT incidence in the Turkish-Cypriot population, describ

129 These data suggest the incidence of RRT from multiple myeloma in the United States has decre

130 The incidence of RRT is higher than other countries reporting to the Euro

131 ); main secondary outcomes were incidence of RRT use and in-hospital mortality.

132 [39.3%]) compared with delayed initiation of RRT (65 of 119 patients [54.7%]; hazard ratio [HR], 0.66

133 ts in the Early Versus Delayed Initiation of RRT in Critically Ill Patients with AKI (ELAIN) Trial fr

134 Whether earlier initiation of RRT in critically ill patients with AKI can improve outc

135 In conclusion, early initiation of RRT in these critically ill patients with AKI significan

136 arly RRT compared with delayed initiation of RRT reduced mortality over the first 90 days.

137 Early initiation of RRT significantly reduced 90-day mortality (44 of 112 pa

138 AKI or no initiation; n = 119) initiation of RRT.

139 t vascular access, and delayed initiation of RRT.

140 ucation and uninformed choice of modality of RRT, delayed placement of a permanent vascular access, a

141 inary team management, and transition off of RRT.

142 ce (white/black/other), and year of onset of RRT (+/-1 year) but had not received a transplant on ind

143 Using number of days from onset of RRT to transplantation as the index date for cases, we s

144 ars associated with the composite outcome of RRT or mortality, regardless of COVID-19 status.

145 ty and should be used as an integral part of RRT programmes.

146 teinuria was also a significant predictor of RRT after CF-LVAD implantation.

147 /=0.55 mg/mg) were significant predictors of RRT after CF-LVAD support.

148 son regression to estimate the prevalence of RRT for countries without reported data.

149 The age-adjusted prevalence of RRT in Turkish-Cypriots was 1543 pmp on 01/01/2011.

150 nt of stage 3 AKI (n=25 [32.5%]), receipt of RRT (n=11 [14.2%]), or inpatient mortality (n=16 [20.7%]

151 ed to 0.90+/-0.06 and the AUC for receipt of RRT improved to 0.91+/-0.08.

152 t increased risk for mortality or receipt of RRT over the next 9 months.

153 , recovery of renal function, requirement of RRT after day 90, duration of renal support, and intensi

154 was no significant effect on requirement of RRT after day 90, organ dysfunction, and length of ICU s

155 ion rate and proteinuria had highest risk of RRT (63.6%) compared with those with either low estimate

156 ccurate clinical prediction of the timing of RRT and adequate patient preparation.

157 -term outcomes associated with the timing of RRT initiation in such patients.

158 etermine the effect of necessity and type of RRT on patient survival after OLTX.

159 RRT, when they received RRT, and the type of RRT.

160 .52 [95% CI, 0.37-0.75]; P <.001) and use of RRT (odds ratio, 0.52 [95% CI, 0.33-0.81]; P = .004).

161 Despite the growing use of RRT in the cardiac intensive care unit, there are few re

162 Use of RRT increased from 8.29% in period I to 12.45% in period

163 Worldwide use of RRT is projected to more than double to 5.439 million (3

164 6.4%-10%; n = 65) (P <.001), and the use of RRT was 10% (95% CI, 8.1%-12%; n = 78) vs 6.3% (95% CI,

165 e composite of in-hospital mortality, use of RRT, and persistent elevated serum creatinine >/=200% fr

166 y, we examined severe AKI, defined as use of RRT, as a primary outcome.

167 decrease in the incidence of AKI and use of RRT.

168 per 100 person-years in the first 3 years of RRT, respectively, compared with 32.3, 20.6, and 21.3 in

169 The data demonstrate that dependency on RRT in the first week after orthotopic liver transplanta

170 to discharge, one in three still depends on RRT at discharge, and one in six remains RRT dependent 6

171 urvival of patients with multiple myeloma on RRT has improved.

172 e applied back to individual patients not on RRT (including patients prescribed intermittent dialysis

173 e applied back to individual patients not on RRT (including patients prescribed intermittent dialysis

174 Whether patients on RRT have an additional risk because of their specific ex

175 ion-wide registry study in adult patients on RRT versus the general population from March 2 to May 25

176 and, eventually, outcomes among patients on RRT.

177 SARS-CoV-2 infection is high in patients on RRT.

178 rtality burden of COVID-19 among patients on RRT.

179 rvival of 73.6% in those patients started on RRT preoperatively, P=0.03.

180 Six patients were on RRT at time of biopsy.

181 in colistin clearance when patients were on RRT was determined from the population analysis and guid

182 e that short- and long-term risk of death or RRT is greatest when patients meet both the serum creati

183 P7] levels>0.3 were associated with death or RRT only in subjects who developed AKI (compared with le

184 uction in the composite in-hospital death or RRT, with patients having lower preoperative renal funct

185 transcription (RT)-PCR and real-time RT-PCR (RRT-PCR).

186 A real-time reverse transcriptase PCR (RRT-PCR) assay based on the avian influenza virus matrix

187 A real-time reverse-transcription PCR (RRT-PCR) was developed to detect avian paramyxovirus 1 (

188 , 7-day AKI or on the need for postoperative RRT after adjustments for confounders.

189 the only biomarker to significantly predict RRT (0.86+/-0.08; P=0.001).

190 ltration rate and proteinuria are predictors RRT after CF-LVAD implantation and should be routinely a

191 In period I, patients receiving preoperative RRT had a 90-day mortality (0%) and a 1-year survival (8

192 Providing RRT in Ebola virus disease is complex and requires metic

193 tients (90.8%) in the delayed group received RRT.

194 In 2010, 2.618 million people received RRT worldwide.

195 or not they received RRT, when they received RRT, and the type of RRT.

196 oups defined on whether or not they received RRT, when they received RRT, and the type of RRT.

197 A total of 15 of 20 patients who received RRT and 111 of 121 who did not were correctly classified

198 -hospital mortality in patients who received RRT services.

199 non-end-stage CKD and 1,728 (1.1%) receiving RRT.

200 t of an algorithm for patients not receiving RRT was based upon the relationship between the dose of

201 907 million people needing but not receiving RRT; conservative model) and Africa (432,000 people; con

202 D patients are seen within 90 d of receiving RRT.

203 In patients receiving RRT with CHA(2)DS(2)-VASc score >/=2, warfarin was assoc

204 For patients receiving RRT, target attainment rates were >80% with the proposed

205 The large number of people receiving RRT and the substantial number without access to it show

206 endent at discharge, and 39 (18.1%) remained RRT dependent 60 days after ICU admission.

207 216 patients discharged, 73 (33.8%) remained RRT dependent at discharge, and 39 (18.1%) remained RRT

208 diagnosis with children (n=125) who remained RRT-free when the corresponding case initiated RRT (cont

209 on RRT at discharge, and one in six remains RRT dependent 60 days after ICU admission.

210 l timing of initiation of renal replacement (RRT) therapy has been debated.

211 ikely than those without COVID-19 to require RRT and were less likely to recover kidney function.

212 Forty-four patients (11.6%) required RRT during a median follow-up of 9.9 months.

213 entical to those patients who never required RRT (1.7% and 90.6%).

214 In patients that required RRT 1-year mortality was 28.2% (log-rank test P = 0.001)

215 enal failure postoperatively, which required RRT, regardless of therapy, had a 1-year survival of onl

216 In multivariable analysis only AKI requiring RRT was an independent predictor of 1-year mortality (ha

217 d critically ill patients with AKI requiring RRT who were enrolled in the study.

218 n critically ill patients with AKI requiring RRT.

219 e 40 years of age and others never requiring RRT.

220 h 6.9% and 88.6% in patients never requiring RRT.

221 In period II, patients requiring RRT had a 90-day mortality of 39.7% and a 1-year actuari

222 Patients requiring RRT had significantly worse renal function, lower hemogl

223 cute renal failure postoperatively requiring RRT, however, had a 90-day mortality of 28.6% and a 1-ye

224 Twenty-eight patients required early RRT (RRT initiated within 1 wk of transplant); 23 for control

225 ng motifs related to the sequence RRTGXPPXL (RRT motif).

226 y and specificity of the H7- and H5-specific RRT-PCR were similar to those of VI and HI.

227 Influenza virus-specific RRT-PCR results correlated with VI results for 89% of th

228 le Ebola virus genetic material in the spent RRT effluent waste.

229 and non-Hispanic white children who started RRT between 1995 and 2011 and were followed through 2012

230 revalence of obesity among children starting RRT may impede kidney transplantation, especially from l

231 Introduction of a rapid response team (RRT) has been shown to decrease mortality and cardiopulm

232 system that included a rapid response team (RRT) led by physician assistants with specialized critic

233 l emergency team (MET), rapid response team (RRT), or critical care outreach (CCO).

234 e techniques (Randomized Response Technique (RRT); projective questioning (PQ); brief implicit associ

235 ine doubling and/or ESRD requiring long-term RRT.

236 uggest the presence of a second gene, termed RRT, that regulates resistance to TCV.

237 It is currently recommended that RRT be instituted once the GFR falls below 10.5 ml/min p

238 The RRT included a pediatric ICU-trained fellow or attending

239 The RRT-PCR assay utilizes a one-step RT-PCR protocol and fl

240 The RRT-PCR test was further simplified with the use of lyop

241 The RRT-PCR test was used to examine clinical samples from c

242 The RRT-PCR with the bead reagents was more sensitive than t

243 ositive correlation was obtained between the RRT-PCR results and virus isolation for NDV from clinica

244 conclude that SA enhances resistance in the RRT background by upregulating HRT expression.

245 tation often occurred within two days of the RRT event and many patients (46.8%) died within one day

246 82% and decreased to 2.35% by the end of the RRT year.

247 , indicating a high level of accuracy of the RRT-PCR assay.

248 There was 97 to 100% agreement of the RRT-PCR test results with VI for tracheal swabs and 81%

249 heless, the epidemic's overall effect on the RRT population remained remarkably limited in Flanders.

250 ome) and need for renal replacement therapy (RRT) (secondary outcome) in STEC-infected children witho

251 death or incident renal replacement therapy (RRT) across strata of preoperative renal function.

252 P=0.03), whereas renal replacement therapy (RRT) and Aspergillus colonization were significant predi

253 ced in supporting Renal Replacement Therapy (RRT) and providing equitable patient care, despite recen

254 l before onset of renal replacement therapy (RRT) and the likelihood of receiving a renal transplant.

255 worldwide use of renal replacement therapy (RRT) are expected to rise sharply in the next decade.

256 mmonly started on renal replacement therapy (RRT) as soon as (or, in some centers, before) the usual

257 dy endpoints were renal replacement therapy (RRT) at 1 month and the need for kidney transplantation

258 the initiation of renal replacement therapy (RRT) at an estimated GFR >/=10 ml/min per 1.73 m(2).

259 the first year of renal replacement therapy (RRT) between elderly patients starting treatment on hemo

260 ho do not receive renal replacement therapy (RRT) develop signs and symptoms of heart failure, includ

261 The need for renal replacement therapy (RRT) either before or after orthotopic liver transplant

262 of initiation of renal replacement therapy (RRT) for severe acute kidney injury (AKI) but without li

263 failure requiring renal replacement therapy (RRT) has detrimental effects on quality of life and surv

264 for postoperative renal replacement therapy (RRT) in patients undergoing liver transplantation.

265 r of the need for renal replacement therapy (RRT) in the first month post-LT.

266 ll those starting renal replacement therapy (RRT) in this population.

267 the incidence of renal replacement therapy (RRT) initiation over the life course of pediatric kidney

268 many situations, renal replacement therapy (RRT) may be associated with complications, and the appro

269 ted the effect of renal replacement therapy (RRT) on serum ammonia level and outcomes in ALF.

270 medical care and renal replacement therapy (RRT) the morbidity, mortality and cost of postoperative

271 hed AKI requiring renal replacement therapy (RRT) were excluded.

272 with preoperative renal replacement therapy (RRT) were excluded.

273 min; 29 receiving renal replacement therapy (RRT)) were subjected to population pharmacokinetic analy

274 min; 29 receiving renal replacement therapy (RRT)) were subjected to population pharmacokinetic analy

275 kidney function, renal replacement therapy (RRT), and death.

276 e preparation for renal replacement therapy (RRT), and timely initiation of dialysis.

277 uded the need for renal replacement therapy (RRT), length of stay in ICU and hospital, and survival.

278 for postoperative renal replacement therapy (RRT), postoperative red blood cells transfusions, time t

279 eir first year of renal replacement therapy (RRT).

280 he cornerstone of renal replacement therapy (RRT).

281 nts (5%) required renal replacement therapy (RRT).

282 intubation (65%), renal replacement therapy (RRT; 33%), and mortality (42%).

283 he requirement of renal replacement therapy (RRT; 56.6% vs. 80%; P = 0.006) and improved 28-day survi

284 y (AKI) requiring renal replacement therapy (RRT; also known as kidney replacement therapy).

285 renal failure and renal replacement therapy [RRT]) and bone events (incident hip, vertebral, and all

286 e.g., patients on renal replacement therapy [RRT]) was estimated using Cox regression analyses.

287 tion times, RT, or relative retention times, RRT, and abundance ratios, AR, of characteristic ions of

288 3) from meeting full eligibility criteria to RRT initiation was significantly shorter in the early gr

289 Estimated durations of time to RRT after disease onset for 99% of the nonglomerular and

290 n named as regulators of rDNA transcription (RRT).

291 This study comprised all patients undergoing RRT in the Flanders region of Belgium, a country that ha

292 patients) were managed conservatively until RRT was judged necessary by their chosen dialysis or tra

293 armers' badger killing behavior reported via RRT.

294 Primary end point was RRT initiation or >50% reduction in initial eGFR.

295 To determine whether RRT can safely be deferred beyond this point, adults wit

296 was to identify risk factors associated with RRT after CF-LVAD implantation.

297 few studies have focused on AKI treated with RRT (AKI-RRT).

298 th ESRD due to multiple myeloma treated with RRT (n=12,703).

299 of non-Hispanic black children treated with RRT.

300 on were analyzed in patients with or without RRT after CF-LVAD implantation.